Federated Hermes, Inc. Sana Biotechnology, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 3 shares of SANA stock, worth $9. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 13, 2024	BUY	$3.76 - $6.86 $11 - $20	3 New	3 $0
Q4 2022 Feb 13, 2023	BUY	$3.19 - $6.46 $832,271 - $1.69 Million	260,900 New	260,900 $1.03 Million

Others Institutions Holding SANA

# of Institutions

172

Shares Held

121M

Call Options Held

1.87M

Put Options Held

1.48M

Flagship Pioneering Inc. Cambridge, MA

25M
Shares

$80.5 Million
17.65% of portfolio
Vanguard Group Inc Valley Forge, PA

13.2M
Shares

$42.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11M
Shares

$35.6 Million
0.0% of portfolio
Baillie Gifford & CO

10.2M
Shares

$33 Million
0.01% of portfolio
Canada Pension Plan Investment Board Toronto Ontario, A6

10.2M
Shares

$32.8 Million
0.04% of portfolio

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $613M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account